Physician profile
James D Railey
NPI 1760446579
$2,977.31
in general payments reported to CMS, 2019-2025
29 companies · $238 in 2025
The $238 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,684 · 2020: $142 · 2021: $42.81 · 2022: $298 · 2024: $573 · 2025: $238.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $810.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $810.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $459.45 | 2019-2025 | Otezla, Repatha |
| Pfizer INC. | $337.95 | 2019-2024 | |
| Novo Nordisk INC | $301.21 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $235.85 | 2019-2022 | |
| Idorsia Pharmaceuticals US INC | $217.34 | 2022 | |
| Abbvie INC. | $144.87 | 2021-2024 | |
| Lilly USA, LLC | $142.17 | 2019-2022 | |
| Edwards Lifesciences Corporation | $131.35 | 2024 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Abbott Laboratories | $120.75 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $120.41 | 2019-2020 | |
| Glaxosmithkline, LLC. | $103.44 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $100.55 | 2024 | |
| Inspire Medical Systems, INC. | $92.70 | 2024 | Inspire |
| Stimwave Technologies Incorporated | $70.05 | 2019 | |
| Novartis Pharmaceuticals Corporation | $69.12 | 2019 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $50.98 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $46.30 | 2019 | |
| Genentech USA, INC. | $37.42 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $29.98 | 2019 | |
| Astellas Pharma US INC | $29.97 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $25.47 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $18.98 | 2020 | |
| Shire North American Group INC | $15.69 | 2019 | |
| Medtronic USA, INC. | $15.27 | 2019 | |
| Amarin Pharma, INC. | $14.34 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $11.94 | 2019 | |
| Flowonix Medical Incorporated | $11.61 | 2019 | |
| Allergan, INC. | $11.25 | 2020 | |
| Merck Sharp & Dohme LLC | $10.90 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Railey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.